Nanomedicine as an emerging approach against intracellular pathogens
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Diseases such as tuberculosis, hepatitis, and HIV/AIDS are caused by intracellular pathogens and are a major burden to the global medical community. Conventional treatments for these diseases typically consist of long-term therapy with a combination of drugs, which may lead to side effects and contribute to low patient compliance. The pathogens reside within intracellular compartments of the cell, which provide additional barriers to effective treatment. Therefore, there is a need for improved and more effective therapies for such intracellular diseases. This review will summarize, for the first time, the intracellular compartments in which pathogens can reside and discuss how nanomedicine has the potential to improve intracellular disease therapy by offering properties such as targeting, sustained drug release, and drug delivery to the pathogen's intracellular location. The characteristics of nanomedicine may prove advantageous in developing improved or alternative therapies for intracellular diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biodegradable nanoparticles for cytosolic delivery of therapeutics
VASIR, J., & LABHASETWAR, V (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.06.003 · Cited by 526 · cited 1×
“Nanoparticles can be internalized by endocytic mechanisms, which include receptor-mediated or clathrincoated pit endocytosis.(102) Nanoparticles may reside within acidic endolysosome compartments following endocytosis,(79) and premature drug release within this acidic compartment may cause drug degradation and render…”
Antibiotic consumption and link to resistance
Goossens, H. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.02725.x · Cited by 379 · cited 1×
“In addition, drug resistance may be developed when patients do not fully comply with their treat-ment regimens 28 or when pathogens are exposed to drugs at suboptimal concentrations 67 for an extended time period.”
Lee, H., Fonge, H., Hoang, B., Reilly, R. M., & Allen, C. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100038h · Cited by 349
Viral entry mechanisms: cellular and viral mediators of herpes simplex virus entry
Akhtar, J., & Shukla, D. (2009) · The FEBS Journal · doi:10.1111/j.1742-4658.2009.07402.x · Cited by 292 · cited 1×
“After reviewing the literature, we found evidence that intra-cellular pathogens reside in phagosomes, 15,34,56 vacuoles, 52,53 cytosol, 16,57,58 and nucleus, 1,59,60 and may interact with the Golgi apparatus 61 and endoplasmic reticulum 62–66 of host cells (Figure 1).”
Recent advances in PEG–PLA block copolymer nanoparticles
Zeng, Z. (2010) · International Journal of Nanomedicine · doi:10.2147/ijn.s14912 · Cited by 264 · cited 1×
“cally improve the therapeutic capacity of the nanoparticle.(83,86) Chitosan and alginate are polymers derived from natural sources and may offer more “friendly” conditions for the encapsulation or incorporation of DNA or peptides, because the use of organic solvents can be avoided.”
Liposome-encapsulated aminoglycosides in pre-clinical and clinical studies
Schiffelers, R. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/48.3.333 · Cited by 163 · cited 2×
“Liposomes are composed of lipid bilayers surrounding a hydrophilic “core” and can be designed to incorporate hydrophobic drugs within the lipid bilayer or hydrophilic drugs within the aqueous core.(94) Liposome-encapsulated aminoglycosides (such as gentamicin) have shown higher therapeutic efficacy than conventional a…”
Cited by
Mesoporous silica nanoparticles in medicine—Recent advances
Mamaeva, V., Sahlgren, C., & Lindén, M. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.07.018 · Cited by 707
Nanotechnology approaches for global infectious diseases
Kirtane, A. R., Verma, M., Karandikar, P., Furin, J., Langer, R., & Traverso, G. (2021) · Nature Nanotechnology · doi:10.1038/s41565-021-00866-8 · Cited by 520
Current applications of nanoparticles in infectious diseases
Zazo, H., Colino, C. I., & Lanao, J. M. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.01.008 · Cited by 434
Yeh, Y.-C., Huang, T.-H., Yang, S.-C., Chen, C.-C., & Fang, J.-Y. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.00286 · Cited by 416
Lactoferrin: a natural Glycoprotein involved in iron and inflammatory homeostasis
Rosa, L., Cutone, A., Lepanto, M., Paesano, R., & Valenti, P. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091985 · Cited by 376
“In addition, antibiotic therapies are not always effective at eradicating intracellular pathogens [101].”
Background
Metadata
- Authors
- Li, B., & Armstead
- Venue
- International Journal of Nanomedicine
- Publisher
- Informa UK Limited
- Published
- 2011-12
- Volume
- 6
- Pages
- 3281
- ISSN
- 1176-9114 (ISSN-L)
- 1178-2013
- OpenAlex
- W2091800702
- Cited by
- 131
- References
- 6
- FWCI
- 4.20
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Nanomedicine as an emerging approach against intracellular pathogens. https://app.cochat.ai/papers/10.2147/ijn.s27285
- The paper
- Li, B., & Armstead. (2011). Nanomedicine as an emerging approach against intracellular pathogens. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s27285
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.